Revvity Inc (RVTY) Actualités

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities

Form 144/A - Report of proposed sale of securities: [Amend]

Revvity To Hold Earnings Call on Monday, November 4, 2024

Revvity, Inc. (NYSE: RVTY), today announced that it will release its third quarter 2024 financial results prior to market open on Monday...

Revvity's EUROIMMUN Launches Solution for Specific Typing of Alzheimer's Disease Associated APOE Gene

APOE genotyping allows assessment of a patient’s risk for adverse effects from new anti-amyloid therapy for Alzheimer’s Revvity, Inc. (NYSE:...

Form 4 - Statement of changes in beneficial ownership of securities

Revvity to Present at Upcoming Investor Conferences

Revvity, Inc. (NYSE: RVTY), today announced it will present at the following investor conferences in September 2024: 2024 Wells Fargo Healthcare...

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 144/A - Report of proposed sale of securities: [Amend]

Form 144 - Report of proposed sale of securities